$10.98
0.080.73%
At Close: -
$10.98
00.00%
After Hours: 4:39 PM EDT
15 minutes delayed
Cogent Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cogent Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.59 | $-0.56 | -5.36 % |
Mar 2024 | 2024-05-07 | $-0.62 | $-0.51 | -21.6 % |
Dec 2023 | 2024-02-26 | $-0.63 | $-0.55 | -14.5 % |
Sep 2023 | 2023-11-02 | $-0.64 | $-0.50 | -28.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Cogent Biosciences (COGT) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.59, which missed the estimate of $-0.56.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.